News and events

Discover the latest events, achievements, and news from our lab.
September 2026 - Conferences and updates

Over the past few weeks, members of the lab have been out and about at conferences and research events, presenting our latest work and connecting with researchers from across the field.

Miro attended the Nordic EMBL in Umeå, where he presented both a poster on CH. Mikko also joined to present a talk, discussing the lab's latest work.

Juuso and Emil have attended the 1st Scientific Workshop by the European School of Hematology in Dublin, Ireland. Here Juuso presented a poster of his work whilst learning about data science and AI and how they will affect hematology research and development.

It was a great opportunity to share our research, exchange ideas, and catch up with colleagues from across the research community. We look forward to bringing these conversations and new ideas back to the lab!

September 2026 - CHRG welcomes new lab members!

The Clonal Hematopoeisis Research Group is warmly welcoming three new members this month. Dr. Sebastian May-Wilson is joining as a Senior Post-Doc, Jana Pennonen is joining as the new Lab manager, and Uliana Potychinskaia is joining as a new PhD student.

Welcome to the group!

September 2026 - Mikko Myllymäki earns ERC Starter grant

Mikko Myllymäki has been awarded the prestigious European Research Council (ERC) Starting Grant, which supports outstanding early-career researchers in establishing independent research programmes. The grant provides substantial funding for up to five years, enabling researchers to pursue ambitious, innovative research and expand their research teams. Mikko said "This 5-year funding will help us discover the mechanisms of aging-related inflammation."

Congratulations to Mikko on this fantastic achievement!

 

March 2026 - Mikko Myllymäki starts as FIMM group leader

The lab is excited to announce the next step in its research journey, as Mikko Myllymäki has joined the Institute for Molecular Medicine Finland (FIMM) as a Group Leader. Based at FIMM, the group will continue to investigate clonal haematopoiesis and the genetic and biological processes underlying blood and age-related diseases, bringing together population-scale genomics with experimental and clinical research. This new position provides an opportunity to expand the group’s research programme and build a team focused on understanding the consequences of clonal changes in blood and their implications for human health.